Monday, June 17, 2024

🌎 Palantir Technologies Initiated, Louisiana-Pacific Downgraded, Brighthouse Financial Upgraded and more...

Ratings changes for Warner Bros. Discovery, Lexicon Pharmaceuticals, Micron Technology, Micron Technology, Lovesac, Zscaler, Agios Pharmaceuticals and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
June 17th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Best Buy (NYSE:BBY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $106.00 price target on the stock, up previously from $85.00. This represents a 17.6% upside from the current price of $90.13.
  • Brighthouse Financial (NASDAQ:BHF) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to a "market perform" rating. They now have a $47.00 price target on the stock, down previously from $48.00. This represents a 13.3% upside from the current price of $41.50.
  • Capri (NYSE:CPRI) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $41.00 price target on the stock. This represents a 26.2% upside from the current price of $32.50.
  • Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $4.00. This represents a 67.1% upside from the current price of $3.59.
  • Greif (NYSE:GEF) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $77.00 price target on the stock, up previously from $76.00. This represents a 25.6% upside from the current price of $61.30.
  • Corning (NYSE:GLW) was upgraded by analysts at Fox Advisors from an "equal weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock. This represents a 16.0% upside from the current price of $38.79.
  • ICU Medical (NASDAQ:ICUI) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $135.00 price target on the stock. This represents a 14.1% upside from the current price of $118.30.
  • Itaú Unibanco (NYSE:ITUB) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.The current price is $5.88.
  • Keurig Dr Pepper (NASDAQ:KDP) was upgraded by analysts at Truist Financial Co. from a "sell" rating to a "hold" rating. They now have a $34.00 price target on the stock, up previously from $27.00. This represents a 0.8% downside from the current price of $34.27.
  • Newmont (NYSE:NEM) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock, up previously from $40.00. This represents a 22.5% upside from the current price of $40.81.
  • Ollie's Bargain Outlet (NASDAQ:OLLI) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $105.00 price target on the stock. This represents a 12.5% upside from the current price of $93.30.
  • Public Service Enterprise Group (NYSE:PEG) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $82.00 price target on the stock. This represents a 11.6% upside from the current price of $73.49.
  • Toll Brothers (NYSE:TOL) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $124.00 price target on the stock, up previously from $112.00. This represents a 3.9% upside from the current price of $119.39.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $3.00 price target on the stock, down previously from $41.00. This represents a 59.6% upside from the current price of $1.88.
  • Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $1.88.
  • Louisiana-Pacific (NYSE:LPX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $81.00 price target on the stock, down previously from $89.00. This represents a 7.0% downside from the current price of $87.05.
  • MSC Industrial Direct (NYSE:MSM) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $77.46.
  • MSC Industrial Direct (NYSE:MSM) was downgraded by analysts at Loop Capital from a "buy" rating to a "hold" rating. They now have a $80.00 price target on the stock. This represents a 3.3% upside from the current price of $77.46.
  • Shattuck Labs (NASDAQ:STTK) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $5.66.
  • Union Pacific (NYSE:UNP) was downgraded by analysts at Loop Capital from a "buy" rating to a "hold" rating. They now have a $238.00 price target on the stock, down previously from $276.00. This represents a 7.5% upside from the current price of $221.42.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Alkermes (NASDAQ:ALKS) is now covered by analysts at TD Cowen. They set a "buy" rating and a $34.00 price target on the stock. This represents a 39.4% upside from the current price of $24.39.
  • Bowhead Specialty (NYSE:BOW) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $30.00 price target on the stock. This represents a 20.3% upside from the current price of $24.93.
  • Bowhead Specialty (NYSE:BOW) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $26.00 price target on the stock. This represents a 4.3% upside from the current price of $24.93.
  • Bowhead Specialty (NYSE:BOW) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $31.00 price target on the stock. This represents a 24.3% upside from the current price of $24.93.
  • Bowhead Specialty (NYSE:BOW) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $27.00 price target on the stock. This represents a 8.3% upside from the current price of $24.93.
  • Bowhead Specialty (NYSE:BOW) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $32.00 price target on the stock. This represents a 28.4% upside from the current price of $24.93.
  • Endeavour Silver (NYSE:EXK) (TSE:EDR) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $6.00 price target on the stock. This represents a 64.4% upside from the current price of $3.65.
  • Farmer Bros. (NASDAQ:FARM) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock. This represents a 98.0% upside from the current price of $3.03.
  • Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $88.00 price target on the stock. This represents a 113.5% upside from the current price of $41.22.
  • Lexicon Pharmaceuticals (NASDAQ:LXRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock. This represents a 437.6% upside from the current price of $1.86.
  • Nayax (NASDAQ:NYAX) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $27.00 price target on the stock. This represents a 18.0% upside from the current price of $22.88.
  • Ooma (NYSE:OOMA) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $14.00 price target on the stock. This represents a 63.6% upside from the current price of $8.56.
  • Pagaya Technologies (NASDAQ:PGY) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 92.1% upside from the current price of $11.97.
  • Palantir Technologies (NYSE:PLTR) is now covered by analysts at Argus. They set a "buy" rating and a $29.00 price target on the stock. This represents a 21.5% upside from the current price of $23.86.
  • Q32 Bio (NASDAQ:QTTB) is now covered by analysts at Guggenheim. They set a "buy" rating and a $100.00 price target on the stock. This represents a 418.1% upside from the current price of $19.30.
  • RenovoRx (NASDAQ:RNXT) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $8.00 price target on the stock. This represents a 501.5% upside from the current price of $1.33.
  • Trade Desk (NASDAQ:TTD) is now covered by analysts at Wedbush. They set an "outperform" rating and a $110.00 price target on the stock. This represents a 14.2% upside from the current price of $96.35.
  • Unusual Machines (NYSEAMERICAN:UMAC) is now covered by analysts at ThinkEquity. They set a "buy" rating and a $4.00 price target on the stock. This represents a 159.7% upside from the current price of $1.54.
  • Veralto (NYSE:VLTO) is now covered by analysts at TD Cowen. They set a "hold" rating and a $95.00 price target on the stock. This represents a 5.3% downside from the current price of $100.29.
  • Xponential Fitness (NYSE:XPOF) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $22.00 price target on the stock. This represents a 54.2% upside from the current price of $14.27.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Musk's new company could top a trillion?

No comments:

Post a Comment

Bill Clinton Backing Biden Replacement???

Do you want to see who I believe will be the next president of the U.S.A? ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...